These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20362512)

  • 1. The significance of the number of CGG repeats and autoantibodies in premature ovarian failure.
    Fiçicioglu C; Yildirim G; Attar R; Kumbak B; Yesildaglar N
    Reprod Biomed Online; 2010 Jun; 20(6):776-82. PubMed ID: 20362512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test?
    Gleicher N; Weghofer A; Oktay K; Barad DH
    Acta Obstet Gynecol Scand; 2009; 88(9):1024-30. PubMed ID: 19642041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone.
    Gleicher N; Weghofer A; Barad DH
    Fertil Steril; 2009 May; 91(5):1700-6. PubMed ID: 18384775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies.
    Gleicher N; Weghofer A; Barad DH
    Fertil Steril; 2009 May; 91(5):1707-11. PubMed ID: 18384784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
    Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
    Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the number of CGG repeats and serum level of anti-Müllerian hormone in women without FMR1 premutation.
    Choe SA; Kim KC; Lee JY; Kim CH; Hwang D; Jee BC
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):275-8. PubMed ID: 23731704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
    Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
    Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of FMR1 gene association with ovarian dysfunction in a sample from the Basque Country.
    Barasoain M; Barrenetxea G; Huerta I; Télez M; Carrillo A; Pérez C; Criado B; Arrieta I
    Gene; 2013 May; 521(1):145-9. PubMed ID: 23537988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging?
    Gleicher N; Weghofer A; Oktay K; Barad DH
    Menopause; 2009; 16(4):760-4. PubMed ID: 19197218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of CGG repeats in the FMR1 gene and timing of natural menopause.
    Voorhuis M; Onland-Moret NC; Fauser BC; Ploos van Amstel HK; van der Schouw YT; Broekmans FJ
    Hum Reprod; 2013 Feb; 28(2):496-501. PubMed ID: 23154068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve.
    Gleicher N; Weghofer A; Oktay K; Barad D
    Reprod Biomed Online; 2009 Sep; 19(3):385-90. PubMed ID: 19778484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)?
    Gleicher N; Weghofer A; Oktay K; Barad D
    Hum Reprod; 2009 Oct; 24(10):2395-400. PubMed ID: 19617205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis.
    Bibi G; Malcov M; Yuval Y; Reches A; Ben-Yosef D; Almog B; Amit A; Azem F
    Fertil Steril; 2010 Aug; 94(3):869-74. PubMed ID: 19481741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome.
    Tejada MI; García-Alegría E; Bilbao A; Martínez-Bouzas C; Beristain E; Poch M; Ramos-Arroyo MA; López B; Fernandez Carvajal I; Ribate MP; Ramos F
    Menopause; 2008; 15(5):945-9. PubMed ID: 18427356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat level.
    Pastore LM; McMurry TL; Williams CD; Baker VL; Young SL
    J Assist Reprod Genet; 2014 Oct; 31(10):1295-301. PubMed ID: 24938362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGG repeat sizing in the FMR1 gene in Indian women with premature ovarian failure.
    Chatterjee S; Maitra A; Kadam S; Patel Z; Gokral J; Meherji P
    Reprod Biomed Online; 2009 Aug; 19(2):281-6. PubMed ID: 19712568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of CGG repeats in FMR1 in Chinese women with idiopathic premature ovarian failure.
    Ye Y; Lan X; Cong J; Li N; Wu Y; Zhang M; Liu J; Cui Y; Wu BL; An Y; Wu J
    Reprod Biomed Online; 2014 Sep; 29(3):382-7. PubMed ID: 24912415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age.
    Kline JK; Kinney AM; Levin B; Brown SA; Hadd AG; Warburton D
    Menopause; 2014 Jul; 21(7):740-8. PubMed ID: 24423935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.